Mutant p53 Enhances Nuclear Factor KB Activation by Tumor Necrosis Factor A in Cancer Cells

Mutations in the p53 tumor suppressor are very frequent in human cancer. Often, such mutations lead to the constitutive overproduction of mutant p53 proteins, which may exert a cancer-promoting gain of function. We now report that cancer-associated mutant p53 can augment the induction of nuclear factor KB (NFKB) transcriptional activity in response to the cytokine tumor necrosis factor A (TNFA). Conversely, down-regulation of endogenous mutant p53 sensitizes cancer cells to the apoptotic effects of TNFA. Analysis of human head and neck tumors and lung tumors reveals a close correlation between the presence of abundant mutant p53 proteins and the constitutive activation of NFKB. Together, these findings suggest that p53 mutations may promote cancer progression by augmenting NFKB activation in the context of chronic inflammation. [Cancer Res 2007;67(6):2396–401]